HLA-DRB1 and myeloid sarcoma: HLA gene variants in HLA-DRB1, HLA-DR3, and HLA-DR4 are well-known determinants of MS susceptibility: the HLA-DRB1*15:01 allele is known to increase the risk of developing MS by over three times.